We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BHC market cap is 4.04B. The company's latest EPS is USD -1.6209 and P/E is -6.81.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.6B | 8.03B | 8.43B | 8.12B | 8.76B |
| Operating Income | -203M | 676M | 450M | 454M | 963M |
| Net Income | -1.79B | -560M | -948M | -225M | -592M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.86B | 31.2B | 29.2B | 25.69B | 27.35B |
| Total Liabilities | 32.73B | 30.59B | 29.24B | 25.43B | 27.43B |
| Total Equity | 1.14B | 605M | -34M | 260M | -82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.5B | 1.11B | 1.43B | -728M | 1.03B |
| Investing | -419M | -261M | 409M | -303M | -2.15B |
| Financing | 1.44B | -2.29B | -1.51B | -474M | 1.48B |
| Market Cap | 4.04B |
| Price to Earnings Ratio | -6.81 |
| Price to Sales Ratio | 0.46 |
| Price to Cash Ratio | 4.26 |
| Price to Book Ratio | -49.17 |
| Dividend Yield | - |
| Shares Outstanding | 365.24M |
| Average Volume (1 week) | 203.34k |
| Average Volume (1 Month) | 296.83k |
| 52 Week Change | 10.39% |
| 52 Week High | 15.43 |
| 52 Week Low | 5.45 |
| Spread (Intraday) | 0.29 (2.58%) |
| Company Name | Bausch Health Companies Inc |
| Address |
2150 st. elz��ar blvd. west quebec city, quebec H7L 4A8 |
| Website | https://www.bauschhealth.com |
| Industry | drugs (2830) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
